Pharmaceutical Science Advisory Committee
Executive Summary
Collaborative approaches to scientific research issues of common interest to the pharmaceutical industry, universities, the public and the FDA will be discussed by the committee Dec. 14. Non-clinical study areas to be addressed include interspecies biomarkers of toxicity, high resolution magnetic imaging, positron emission tomography imaging and methods to facilitate early human assessment. The meeting will begin at 8:00 a.m. at the Holiday Inn in Gaithersburg, Md